Robotic-Assisted versus Laparoscopic Left Hemicolectomy-Postoperative Inflammation Status, Short-Term Outcome and Cost Effectiveness
- PMID: 36078317
- PMCID: PMC9517740
- DOI: 10.3390/ijerph191710606
Robotic-Assisted versus Laparoscopic Left Hemicolectomy-Postoperative Inflammation Status, Short-Term Outcome and Cost Effectiveness
Abstract
Robotic-assisted colon surgery may contain advantages over the laparoscopic approach, but clear evidence is sparse. This study aimed to analyze postoperative inflammation status, short-term outcome and cost-effectiveness of robotic-assisted versus laparoscopic left hemicolectomy. All consecutive patients who received minimal-invasive left hemicolectomy at the Department of Surgery I at the University Hospital of Wuerzburg in 2021 were prospectively included. Importantly, no patient selection for either procedure was carried out. The robotic-assisted versus laparoscopic approaches were compared head to head for postoperative short-term outcomes as well as cost-effectiveness. A total of 61 patients were included, with 26 patients having received a robotic-assisted approach. Baseline characteristics did not differ among the groups. Patients receiving a robotic-assisted approach had a significantly decreased length of hospital stay as well as lower rates of complications in comparison to patients who received laparoscopic surgery (n = 35). In addition, C-reactive protein as a marker of systemic stress response was significantly reduced postoperatively in patients who were operated on in a robotic-assisted manner. Consequently, robotic-assisted surgery could be performed in a cost-effective manner. Thus, robotic-assisted left hemicolectomy represents a safe and cost-effective procedure and might improve patient outcomes in comparison to laparoscopic surgery.
Keywords: colon resection; cost-effectiveness; left hemicolectomy; postoperative inflammation; robotic surgery.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Kitano S., Inomata M., Mizusawa J., Katayama H., Watanabe M., Yamamoto S., Ito M., Saito S., Fujii S., Konishi F., et al. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): A phase 3, randomised controlled trial. Lancet Gastroenterol. Hepatol. 2017;2:261–268. doi: 10.1016/S2468-1253(16)30207-2. - DOI - PubMed
-
- van der Sluis P.C., van der Horst S., May A.M., Schippers C., Brosens L.A.A., Joore H.C.A., Kroese C.C., Mohammad N.H., Mook S., Vleggaar F.P., et al. Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial. Ann. Surg. 2019;269:621–630. doi: 10.1097/SLA.0000000000003031. - DOI - PubMed
-
- Jayne D., Pigazzi A., Marshall H., Croft J., Corrigan N., Copeland J., Quirke P., West N., Rautio T., Thomassen N., et al. Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. JAMA. 2017;318:1569–1580. doi: 10.1001/jama.2017.7219. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
